<svg     style="vertical-align:-0.0pt;width:27.6625px;" id="M1" height="20.85" version="1.1" viewBox="0 0 27.6625 20.85" width="27.6625"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.016,-0,0,-.016,.062,10.025)"><path id="x31" d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" /></g><g transform="matrix(.016,-0,0,-.016,7.594,10.025)"><path id="x38" d="M249 635q70 0 116 -43t46 -105q0 -46 -28 -80q-22 -25 -80 -64q62 -35 97 -75t35 -99q0 -81 -63 -131t-135 -50q-83 0 -137.5 45.5t-54.5 123.5q0 52 45 95q29 28 89 64q-109 62 -109 155q0 66 50.5 115t128.5 49zM238 603q-42 0 -67.5 -31t-25.5 -72q0 -50 32.5 -79.5
t98.5 -62.5q61 48 61 124q0 59 -29.5 90t-69.5 31zM248 20q46 0 76.5 33.5t30.5 89.5q0 50 -39 85.5t-110 71.5q-81 -54 -81 -137q0 -67 35.5 -105t87.5 -38z" /></g>

			<g transform="matrix(.022,-0,0,-.022,15.75,20.788)"><path id="x46" d="M493 503l-29 -4q-13 56 -28 80q-13 22 -35.5 29.5t-78.5 7.5h-76q-22 0 -27.5 -5t-5.5 -27v-238h103q66 0 82.5 12t25.5 62h29v-193h-29q-9 54 -25.5 67t-82.5 13h-103v-181q0 -64 15 -78.5t84 -19.5v-28h-272v28q61 5 74.5 19.5t13.5 78.5v399q0 64 -13 78t-72 19v28
h440q1 -40 10 -147z" /></g>

		
	
</svg>-FLT PET/CT in Patients with Gastric Carcinoma

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Histopathology</td><td align="center"><span style="width: 14.9875px;"><svg height="11.3125" id="M14" style="vertical-align:-0.1092pt" version="1.1" viewbox="0 0 14.9875 11.3125" width="14.9875" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.113)"><path d="M857 650l-6 -28q-44 -4 -61.5 -16.5t-29.5 -48.5q-11 -32 -37 -166l-78 -399h-29l-351 537h-4l-56 -276q-24 -120 -24 -164q0 -35 17.5 -46t75.5 -15l-6 -28h-245l7 28q41 2 62 14t31 44q10 30 41 171l53 245q8 44 6.5 60.5t-14.5 33.5q-10 15 -27 19.5t-64 6.5l6 28h153
l350 -516h5l48 257q25 131 25 171q0 34 -17.5 45t-77.5 15l7 28h240z" id="x1D441"></path></g>
</svg></span></td><td align="center">Total</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">AdenoCa tubulare</td><td align="center">57</td><td align="center" rowspan="4">94</td></tr><tr><td align="left">Mucinous adenoCa</td><td align="center">17</td></tr><tr><td align="left">Undifferentiated carcinoma</td><td align="center">6</td></tr><tr><td align="left">AdenoCa partim mucocellulare</td><td align="center">14</td></tr><tr><td align="left" colspan="3"><hr/></td></tr><tr><td align="left">Lauren type intestinal</td><td align="center">38</td><td align="center" rowspan="2">88</td></tr><tr><td align="left">Lauren type nonintestinal</td><td align="center">50</td></tr><tr><td align="left" colspan="3"><hr/></td></tr><tr><td align="left">G2</td><td align="center">28</td><td align="center" rowspan="2">78</td></tr><tr><td align="left">G3</td><td align="center">50</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Histopathology of diagnosed gastric cancers.

Gastroenterology Research and Practice

tab1

Table 1

Table 1: <svg     style="vertical-align:-0.0pt;width:27.6625px;" id="M1" height="20.85" version="1.1" viewBox="0 0 27.6625 20.85" width="27.6625"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.016,-0,0,-.016,.062,10.025)"><path id="x31" d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" /></g><g transform="matrix(.016,-0,0,-.016,7.594,10.025)"><path id="x38" d="M249 635q70 0 116 -43t46 -105q0 -46 -28 -80q-22 -25 -80 -64q62 -35 97 -75t35 -99q0 -81 -63 -131t-135 -50q-83 0 -137.5 45.5t-54.5 123.5q0 52 45 95q29 28 89 64q-109 62 -109 155q0 66 50.5 115t128.5 49zM238 603q-42 0 -67.5 -31t-25.5 -72q0 -50 32.5 -79.5
t98.5 -62.5q61 48 61 124q0 59 -29.5 90t-69.5 31zM248 20q46 0 76.5 33.5t30.5 89.5q0 50 -39 85.5t-110 71.5q-81 -54 -81 -137q0 -67 35.5 -105t87.5 -38z" /></g>

			<g transform="matrix(.022,-0,0,-.022,15.75,20.788)"><path id="x46" d="M493 503l-29 -4q-13 56 -28 80q-13 22 -35.5 29.5t-78.5 7.5h-76q-22 0 -27.5 -5t-5.5 -27v-238h103q66 0 82.5 12t25.5 62h29v-193h-29q-9 54 -25.5 67t-82.5 13h-103v-181q0 -64 15 -78.5t84 -19.5v-28h-272v28q61 5 74.5 19.5t13.5 78.5v399q0 64 -13 78t-72 19v28
h440q1 -40 10 -147z" /></g>

		
	
</svg>-FLT PET/CT in Patients with Gastric Carcinoma 